1. Surfactant Protein D as a Potential Biomarker and Therapeutic Target in Ovarian Cancer
   Juhi Kumar et al, 2019, Frontiers in Oncology CrossRef
2. Differential Regulation of Genes by the Glucogenic Hormone Asprosin in Ovarian Cancer
   Rachel Kerslake et al, 2022, Journal of Clinical Medicine CrossRef
3. H2A Histone Family Member X (H2AX) Is Upregulated in Ovarian Cancer and Demonstrates Utility as a Prognostic Biomarker in Terms of Overall Survival
   Sayeh Saravi et al, 2020, Journal of Clinical Medicine CrossRef
4. Identification of Potential Bisphenol A (BPA) Exposure Biomarkers in Ovarian Cancer
   Aeman Zahra et al, 2021, Journal of Clinical Medicine CrossRef
5. Carbon nanotube-coated recombinant human surfactant protein D reduces cell viability in an ovarian cancer cell line, SKOV3, and modulates mTOR pathway and pro-inflammatory cytokine response
   Dalal S. Alshaya et al, 2022, Journal of King Saud University - Science CrossRef
6. Differential expression of mTOR components in endometriosis and ovarian cancer: Effects of rapalogues and dual kinase inhibitors on mTORC1 and mTORC2 stoichiometry
   Karly‑Rai Rogers‑Broadway et al, 2018, International Journal of Molecular Medicine CrossRef
7. mTORC1/2 inhibition re-sensitizes platinum-resistant ovarian cancer by disrupting selective translation of DNA damage and survival mRNAs
   Gizelka David-West et al, 2018, Oncotarget CrossRef
8. Kinase Inhibitors and Ovarian Cancer
   null Katopodis et al, 2019, Cancers CrossRef